FBTIX Mutual Fund (Fidelity Advisor Biotechnology Fund Class I) is managed by Fidelity Investments (US) with $776.1M in net assets. FBTIX expense ratio is 0.71%, holding 92 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTIX performance shows a YTD return of 22.57%. The 1-year return is 77.50% and the 5-year return is 12.66%. FBTIX dividend yield stands at 0.94%, paid annually.

FBTIX top holdings include Abbvie Inc (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmace (5.0%), Ascendis Pharma As Adr (4.5%), Cogent Biosciences Inc (3.8%). View all FBTIX holdings, sector breakdown, or dividend history.

FBTIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTIX alternatives are available via the screener, along with tax-loss harvesting opportunities.